CDC vaccine committee to discuss COVID-19 booster doses for immunocompromised

 The Centers for Disease Control and Prevention's influential vaccine advisory committee plans to meet July 22 to discuss the new safety warning for Johnson & Johnson's JNJ, -1.10% COVID-19 vaccine and whether immunocompromised people will need a booster dose of a COVID-19 shot. The CDC's Advisory Committee on Immunization Practices has met several times during the pandemic to discuss COVID-19 vaccines. The meeting will be webcast.

https://www.marketwatch.com/story/cdc-vaccine-committee-to-discuss-covid-19-booster-doses-for-immunocompromised-people-2021-07-15